ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Frist Backs Federal Funding For Stem Cell Research.

July 20, 2001

Budget Process for FY ’81 Starts; Investigators Initiated Definition May Be Heated Issues

August 31, 1979

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

Weicker Ready To Fight for Increased NCI, NIH Funding, Objects to Limits On Grants, Positions

March 14, 1986

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993